LTFS
GNMX

Ladenburg Thalmann Financial Services’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$17K Buy
113,150
+107,000
+1,740% +$14.6K ﹤0.01% 4240
2019
Q3 		$1K Hold
6,150
– – ﹤0.01% 5228
2019
Q2 		$1K Sell
6,150
-447
-7% -$90 ﹤0.01% 5226
2019
Q1 		$1K Buy
6,597
+5,000
+313% +$1.11K ﹤0.01% 5173
2018
Q4 		$1K Hold
1,597
– – ﹤0.01% 5161
2018
Q3 		$2K Buy
1,597
+650
+69% +$727 ﹤0.01% 4937
2018
Q2 		$2K Hold
947
– – ﹤0.01% 4926
2018
Q1 		$2K Hold
947
– – ﹤0.01% 4926
2017
Q4 		$2K Hold
947
– – ﹤0.01% 4837
2017
Q3 		$2K Buy
947
+500
+112% +$639 ﹤0.01% 4728
2017
Q2 		$1K Hold
447
– – ﹤0.01% 4819
2017
Q1 		$1K Hold
447
– – ﹤0.01% 4789
2016
Q4 		$2K Hold
447
– – ﹤0.01% 4583
2016
Q3 		$2K Hold
447
– – ﹤0.01% 4544
2016
Q2 		$2K Hold
447
– – ﹤0.01% 4471
2016
Q1 		$2K Hold
447
– – ﹤0.01% 4434
2015
Q4 		$3K Hold
447
– – ﹤0.01% 4283
2015
Q3 		$3K Sell
447
-1,000
-69% -$7.75K ﹤0.01% 4183
2015
Q2 		$9K Hold
1,447
– – ﹤0.01% 3781
2015
Q1 		$12K Sell
1,447
-5,150
-78% -$38.8K ﹤0.01% 3535
2014
Q4 		$33K Buy
+6,597
New +$32.6K ﹤0.01% 2647

Other funds holding GNMX

AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ladenburg Thalmann Financial Services's GNMX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Aevi Genomic Medicine Inc (GNMX) stake by 1,740% in Q4 2019, buying an estimated $14.6K and bringing the position to 113,150 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #4240.

Ladenburg Thalmann Financial Services first reported a position in GNMX in Q4 2014 and has held it in 21 quarters since. The position peaked at $33K in Q4 2014. 28 funds tracked by Wall St. Rank hold GNMX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 113,150 shares of Aevi Genomic Medicine Inc worth $17K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 107,000 Aevi Genomic Medicine Inc shares in Q4 2019, an estimated $14.6K.
  • Aevi Genomic Medicine Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4240 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Aevi Genomic Medicine Inc in Q4 2014 and has held it in 21 quarters since.
  • Ladenburg Thalmann Financial Services's Aevi Genomic Medicine Inc position peaked at $33K in Q4 2014.
  • 28 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.